Effects of melatonin in children with attention-deficit/hyperactivity disorder with sleep disorders after methylphenidate treatment
暂无分享,去创建一个
S. Cortese | C. Pfanner | Pamela Fantozzi | E. Inguaggiato | G. Masi | Laura Ruglioni | F. Ricci | A. Tacchi | Arianna Villafranca
[1] G. Salmon,et al. Attention deficit hyperactivity disorder. , 2018, British journal of hospital medicine.
[2] D. Purper-Ouakil,et al. Can melatonin prevent or improve metabolic side effects during antipsychotic treatments? , 2017, Neuropsychiatric disease and treatment.
[3] S. Cortese,et al. Safety, Tolerability and Efficacy of Drugs for Treating Behavioural Insomnia in Children with Attention-Deficit/Hyperactivity Disorder: A Systematic Review with Methodological Quality Assessment , 2017, Pediatric Drugs.
[4] S. Cortese,et al. Melatonin for sleep disturbance in children with neurodevelopmental disorders: prospective observational naturalistic study , 2015, Expert review of neurotherapeutics.
[5] R. Kirov,et al. Sleep problems and their effect in ADHD , 2014, Expert review of neurotherapeutics.
[6] G. Salum,et al. ADHD prevalence estimates across three decades: an updated systematic review and meta-regression analysis. , 2013, International journal of epidemiology.
[7] S. Comai,et al. Sleep–wake characterization of double MT1/MT2 receptor knockout mice and comparison with MT1 and MT2 receptor knockout mice , 2013, Behavioural Brain Research.
[8] J. Buitelaar,et al. Practitioner review: current best practice in the management of adverse events during treatment with ADHD medications in children and adolescents. , 2013, Journal of child psychology and psychiatry, and allied disciplines.
[9] R. Appleton,et al. Melatonin: helping to MEND impaired sleep , 2013, Archives of Disease in Childhood.
[10] R. Reiter,et al. A review of the molecular aspects of melatonin’s anti‐inflammatory actions: recent insights and new perspectives , 2013, Journal of pineal research.
[11] K. Furu,et al. Hypnotic drug use among 0–17 year olds during 2004–2011: A nationwide prescription database study , 2012, Scandinavian journal of public health.
[12] E. Walker,et al. Diagnostic and Statistical Manual of Mental Disorders , 2013 .
[13] H. Korzilius,et al. The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis. , 2010, Sleep.
[14] S. Pliszka,et al. Practice parameter for the assessment and treatment of children and adolescents with attention-deficit/hyperactivity disorder. , 2007, Journal of the American Academy of Child and Adolescent Psychiatry.
[15] N. Gordon. The therapeutics of melatonin: a paediatric perspective , 2000, Brain and Development.
[16] N. Ryan,et al. Schedule for Affective Disorders and Schizophrenia for School-Age Children-Present and Lifetime Version (K-SADS-PL): initial reliability and validity data. , 1997, Journal of the American Academy of Child and Adolescent Psychiatry.
[17] A. Wirz-Justice,et al. Melationin: Nature's Soporific? , 1996, Journal of Sleep Research.
[18] M. Mohammadi,et al. Melatonin Effects in Methylphenidate Treated Children with Attention Deficit Hyperactivity Disorder: A Randomized Double Blind Clinical Trial , 2012, Iranian journal of psychiatry.
[19] J. Buitelaar,et al. European clinical guidelines for hyperkinetic disorder – first upgrade , 2004, European Child & Adolescent Psychiatry.
[20] C. Conners. Conners' rating scales-revised : technical manual , 1997 .